ArticleCurrent medical mycology2019
Molecular identification and antifungal susceptibility pattern of
Article in Current medical mycology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025Review
- Article
- Evaluation of Antifungal Activity AgainstHIV/AIDS (Auckland, N.Z.) · 2025Article
- Antifungal susceptibility profile of Candida species and uncommon yeasts from drug abusers with oral candidiasis.BMC oral health · 2024Article
- EpiCandIn: An open online resource for epidemiology of Candida infections in India.The Indian journal of medical research · 2024Article
- Marine Ascomycetes Extract Antifungal Susceptibility against Candida spp. Isolates from Oral Candidiasis HIV/AIDS Patient: An In Vitro Study.European journal of dentistry · 2024Article
- Extensive Diversity and Prevalent Fluconazole Resistance among Environmental Yeasts from Tropical China.Genes · 2022Article
- Detection ofFrontiers in microbiology · 2022Article
- Identification of Fungi Isolated from Oral Cavity of Patients with HIV Using MALDI-TOF MS.Journal of clinical medicine · 2021Article
- Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis.BMC research notes · 2021Article
- Species Diversity and Antifungal Susceptibilities of Oral Yeasts from Patients with Head and Neck Cancer.Infection and drug resistance · 2021Article
- Interactions between invasive fungi and symbiotic bacteria.World journal of microbiology & biotechnology · 2020Review
- An alarming rise of non-albicans Candida species and uncommon yeasts in the clinical samples; a combination of various molecular techniques for identification of etiologic agents.BMC research notes · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeOpportunistic fungal infections have been on a growing trend since the last two decades. Among the opportunistic fungal agents, MATERIALS AND
methodsThis study was conducted on 80 clinical samples collected from HIV-infected patients with suspected candidiasis referring to Tagore Medical College and Hospital, Rathinamangalam and Government Hospital of Thoracic Medicine, in Chennai, India, for 18 months (i.e., May 2016-December 2017). Phenotypic and molecular identification was accomplished using internal transcribed spacer region 1 (ITS1) and ITS4 primers. The antifungal susceptibility pattern of the isolates against four antifungal agents was also determined by both disk diffusion and broth dilution methods.
resultsIn the present study, the prevalence of candidiasis was obtained as 75% (n=60).
conclusionMolecular assay led to the identification of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.